Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?

BACKGROUND AND AIMS: People with type 2 diabetes mellitus (T2DM) have increased morbidity and mortality due to coronavirus disease-19(COVID-19). It has been speculated that use of pioglitazone might increase such risk. The aim of our brief commentary is to review the safety of pioglitazone in people...

Descripción completa

Detalles Bibliográficos
Autores principales: Jagat J, Mukherjee, Kalyan K, Gangopadhyay, Subir, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836749/
https://www.ncbi.nlm.nih.gov/pubmed/32540737
http://dx.doi.org/10.1016/j.dsx.2020.06.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836749/
https://www.ncbi.nlm.nih.gov/pubmed/32540737
http://dx.doi.org/10.1016/j.dsx.2020.06.015

Ejemplares similares